Authors
Peskovets R. D.
postgraduate, Chair of Outpatient Therapy, Family Medicine and Healthy Lifestyle1
Shtarik S. Yu.
Doctor of Medicine, Professor, Chair of Outpatient Therapy, Family Medicine and Healthy Lifestyle1
Evsyukov À. À.
PhD, Assistant Professor, Chair of Outpatient Therapy, Family Medicine and Healthy Lifestyle1
1 - Krasnoyarsk State Medical University named of the Professor V.F. Voyno-Yasenetsky, Krasnoyarsk, Russia
Abstract
The purpose of this study was to assess the prevalence of smoking among the adult population of Krasnoyarsk considering age and gender, presence of arterial hypertension, as well as the receiving of antihypertensive therapy and its effectiveness. The data was obtained from 1123 persons aged 25-34 years, participating in the study «Epidemiology of Cardio-Vascular Diseases in Russian Federation – 2012». According to the results of the study, from the total number of participants hypertension was diagnosed among 44.2% (52.1% of men and 39.6% women, p=0.000), smoking prevalence was 23.9% (39.4% in men and 15.0% among women, p=0.000). The median age of onset of smoking among men was 17 years, median age of onset of smoking among women was 18 years. The prevalence of smoking among men was not significantly changed (p=0.239), and among women decreased with the onset of 45 years (p=0.000). Among men with hypertension and without hypertension, the proportion of smokers was statistically comparable (41.8% vs 36.7%, p=0.296). Among women with hypertension, the proportion of smokers was significantly lower than among women without hypertension (11.3% vs 17.4%, p=0.026). There was no significant association between the use and effectiveness of antihypertensive therapy among men and among women (p>0.05). So, in case of hypertension men continued to smoke, women quitted the habit. Treatment with antihypertensive drugs and the effectiveness of treatment of arterial hypertension did not influence the attitude of patients towards smoking.
Key words
smoking prevalence, hypertension prevalence
References
1. Balanova, Yu. A., A. V. Koncevaya, S. A. Shalnova et al. «The prevalence of behavioral risk factors for cardiovascular disease in the Russian population, results of the study ESSAY-RF.» Profilakticheskaya medicina 17, no. 5 (2014): 42-52.
2. Bojcov, S. A., Yu. A. Balanova, S. A. Shalnova et al. «Arterial hypertension among people aged 25-64: prevalence, awareness, treatment and control. Results from ESSAY study.» Kardiovaskulyarnaya terapiya i profilaktika 13, no. 4 (2014): 4-14.
3. Vihireva, O. V. «Smoking as a risk factor for cardiovascular disease: current problems and the possibility of control by means of nicotine addiction treatment.» Profilaktika zabolevanij i ukreplenie zdorovya, no. 4 (2003): 21-27.
4. Maslennikova, G. Ya., S. A. Martynchik, S. A. Shalnova et al. «Medical and socio-economic losses among the adult population of Russia, caused by smoking.» Profilaktika zabolevanij i ukreplenie zdorovya, no. 3 (2004): 5-9.
5. Hanin, A. L., and T. I. Chernushenko. «The prevalence of smoking in different age and gender groups in a mining town in Western Siberia.» Medicina v Kuzbasse, no. 3 (2012): 22-26.
6. Shalnova, S. A., A. O. Konradi, Yu. A. Karpov et al. «Analysis of mortality from cardiovascular disease in 12 Russian regions participating in the study »Epidemiology of cardiovascular diseases in various regions of Russia«.» Rossijskij kardiologicheskij zhurnal 5, no. 97, 6-11.
7. Shtarik, S. Yu., M. M. Petrova, I. I. Baron et al. «The prevalence of smoking among the adult population of the city of Krasnoyarsk.» Sibirskoe medicinskoe obozrenie, no. 6 (2012): 52-55.
8. Shtarik, S. Yu., R. D. Peskovec, and A. A. Evsyukov. «Physical activity and hypertension in the adult population of a large industrial center in Eastern Siberia.» Uspekhi sovremennogo estestvoznaniya, no. 1-8 (2015): 1291-295.
9. Shtarik, S. Yu., M. M. Petrova, and N. P. Garganeeva. «Certain aspects of the comorbidity of anxiety-depressive disorders and hypertension.» Sibirskij medicinskij zhurnal 24, no. 4-2 (2009): 46-48.
10. Bang, Lia E., Louise Buttenschøn, Kjeld S. Kristensen, and Tage L. Svendsen. «Do we undertreat hypertensive smokers? A comparison between smoking and non-smoking hypertensives.» Blood Pressure Monitoring 5, no. 5 (2000): 271-74. doi:10.1097/00126097-200010000-00004.
11. Groppelli A., Omboni S., Paratiþ G. et al. «Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition.» J Hypertens Suppl 8, no.5 (1990): S35-40.
12. Khuciriski P., Mazur B., Kaufman J. et al. «Assessment of blood serum immunoglobulin and C–reactive protein concentrations in workers of x-ray diagnostics units.» Int J Occup Med Environ Health 18 no.4 (2005): 327-30.
13. Shinton, R., and G. Beevers. «Meta-analysis of relation between cigarette smoking and stroke.» Bmj 298, no. 6676 (1989): 789-94. doi:10.1136/bmj.298.6676.789.
14. Yusuf S., Hawken S., Ounpuu S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTÅRHEART Study): case-control study // Lancet. 2004; T. – 364. – P. 937–952 Yusuf, Salim, Steven Hawken, Stephanie Ôunpuu et.al. «Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.» The Lancet 364, no. 9438 (2004): 937-52. doi:10.1016/s0140-6736(04)17018-9.
